Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1175175 (
SARS
)
19,188
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The spike (S) protein, a main surface antigen of
SARS
-coronavirus (SARS-CoV), is one of the most important antigen candidates for vaccine design. In the present study, three fragments of the truncated S protein were expressed in
E.coli
, and analyzed with pooled sera of convalescence phase of
SARS
patients. The full length S gene DNA vaccine was constructed and used to immunize BALB/c mice. The mouse serum IgG antibody against
SARS
-CoV was measured by ELISA with E. coli expressed truncated S protein or
SARS
-CoV lysate as diagnostic antigen. The results showed that all the three fragments of S protein expressed by
E.coli
was able to react with sera of
SARS
patients and the S gene DNA candidate vaccine could induce the production of specific IgG antibody against
SARS
-CoV efficiently in mice with seroconversion ratio of 75% after 3 times of immunization. These findings lay some foundations for further understanding the immunology of
SARS
-CoV and developing
SARS
vaccines.
...
PMID:DNA vaccine of SARS-Cov S gene induces antibody response in mice. 1473 73
Spike protein is one of the major structural proteins of
severe acute respiratory syndrome
-coronavirus. It is essential for the interaction of the virons with host cell receptors and subsequent fusion of the viral envelop with host cell membrane to allow infection. Some spike proteins of coronavirus, such as MHV, HCoV-OC43, AIBV and BcoV, are proteolytically cleaved into two subunits, S1 and S2. In contrast, TGV, FIPV and HCoV-229E are not. Many studies have shown that the cleavage of spike protein seriously affects its function. In order to investigate the maturation and proteolytic processing of the S protein of
SARS
CoV, we generated S1 and S2 subunit specific antibodies (Abs) as well as N, E and 3CL protein-specific Abs. Our results showed that the antibodies could efficiently and specifically bind to their corresponding proteins from
E.coli
expressed or lysate of
SARS
-CoV infected Vero-E6 cells by Western blot analysis. Furthermore, the anti-S1 and S2 Abs were proved to be capable of binding to
SARS
CoV under electron microscope observation. When S2 Ab was used to perform immune precipitation with lysate of
SARS
-CoV infected cells, a cleaved S2 fragment was detected with S2-specific mAb by Western blot analysis. The data demonstrated that the cleavage of S protein was observed in the lysate, indicating that proteolytic processing of S protein is present in host cells.
...
PMID:The spike protein of severe acute respiratory syndrome (SARS) is cleaved in virus infected Vero-E6 cells. 1545 Jan 34
In this study, the encoding sequences of
SARS
-CoV spike protein were analyzed by bioinformatics methods, the structural characteristics and functions were forecasted based on available data. It suggests that the fragment of spike glycoprotein (S401-659) may be crucial for viral attachment and may be a major immunodominant epitope. Then the fragment was amplified and subcloned into expression vector pET28a(+) and pPIC9K. These two plasmids pET28a(+)-S and pPIC9K-S were transformed to
E.coli
strain BL21(DE3)-star and Pichia pastoris, respectively. SDS-PAGE and Western blot analysis showed that the recombinant protein was successfully expressed. The denatured inclusion bodies were purified with Ni-NTA chelate agarose and its purity can reach 90%.
...
PMID:[A preliminary study of the structure prediction and expression of SARS-CoV spike protein]. 1612 May 90